George K Bertsias

机构：University of Crete, Institute of Molecular Biology and Biotechnology, University Hospital of Heraklion, Foundation for Research and Technology Hellas · ORCID：0000-0001-5299-1406

发表论文 431 篇 · 总被引 24578 次 · h-index 63

代表论文

• EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update (2025 · Annals of the Rheumatic Diseases · 被引 97)
• Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways (2024 · Annals of the Rheumatic Diseases · 被引 24)
• Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus (2025 · Annals of the Rheumatic Diseases · 被引 20)
• Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al (2024 · Annals of the Rheumatic Diseases · 被引 19)
• Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study (2024 · RMD Open · 被引 11)
• Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus (2025 · Annals of the Rheumatic Diseases · 被引 10)